Manulife (Manufacturers Life Insurance)
RCUS icon

Manulife (Manufacturers Life Insurance)’s Arcus Biosciences RCUS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
45,826
+3,656
+9% +$90.4K ﹤0.01% 1781
2026
Q1 		$911K Buy
42,170
+177
+0.4% +$3.82K ﹤0.01% 1879
2025
Q4 		$1M Buy
41,993
+6,963
+20% +$142K ﹤0.01% 1859
2025
Q3 		$476K Sell
35,030
-1,746
-5% -$18.2K ﹤0.01% 2230
2025
Q2 		$299K Buy
36,776
+6,464
+21% +$55.2K ﹤0.01% 2391
2025
Q1 		$238K Buy
30,312
+747
+3% +$8.66K ﹤0.01% 2422
2024
Q4 		$440K Sell
29,565
-763
-3% -$12.5K ﹤0.01% 2300
2024
Q3 		$464K Buy
30,328
+470
+2% +$7.41K ﹤0.01% 2322
2024
Q2 		$455K Buy
29,858
+2,123
+8% +$34.3K ﹤0.01% 2258
2024
Q1 		$524K Buy
27,735
+1,004
+4% +$17.4K ﹤0.01% 2194
2023
Q4 		$511K Sell
26,731
-75
-0.3% -$1.2K ﹤0.01% 2160
2023
Q3 		$481K Sell
26,806
-24,376
-48% -$490K ﹤0.01% 2159
2023
Q2 		$1.04M Buy
51,182
+822
+2% +$15.7K ﹤0.01% 1636
2023
Q1 		$919K Buy
50,360
+79
+0.2% +$1.51K ﹤0.01% 1682
2022
Q4 		$1.03M Buy
50,281
+29,533
+142% +$813K ﹤0.01% 1597
2022
Q3 		$543K Sell
20,748
-451
-2% -$11.9K ﹤0.01% 1926
2022
Q2 		$537K Buy
21,199
+2,236
+12% +$54.8K ﹤0.01% 2006
2022
Q1 		$598K Sell
18,963
-4,148
-18% -$139K ﹤0.01% 2080
2021
Q4 		$935K Sell
23,111
-243
-1% -$9.43K ﹤0.01% 1876
2021
Q3 		$814K Sell
23,354
-2,551
-10% -$79.4K ﹤0.01% 1971
2021
Q2 		$711K Buy
25,905
+1,966
+8% +$56.2K ﹤0.01% 2190
2021
Q1 		$672K Sell
23,939
-1,430
-6% -$49.8K ﹤0.01% 2113
2020
Q4 		$659K Buy
25,369
+1,517
+6% +$36.7K ﹤0.01% 2048
2020
Q3 		$409K Buy
23,852
+4,040
+20% +$90.3K ﹤0.01% 2100
2020
Q2 		$468K Sell
19,812
-1,755
-8% -$47.4K ﹤0.01% 2002
2020
Q1 		$299K Buy
21,567
+732
+4% +$9.1K ﹤0.01% 2093
2019
Q4 		$210K Sell
20,835
-1,322
-6% -$11.1K ﹤0.01% 2566
2019
Q3 		$226K Buy
22,157
+130
+0.6% +$1.04K ﹤0.01% 2506
2019
Q2 		$175K Buy
22,027
+10,084
+84% +$101K ﹤0.01% 2711
2019
Q1 		$149K Buy
+11,943
New +$130K ﹤0.01% 2510

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RCUS Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Arcus Biosciences (RCUS) stake by 8.7% in Q2 2026, buying an estimated $90.4K and bringing the position to 45,826 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Manulife (Manufacturers Life Insurance) first reported a position in RCUS in Q1 2019 and has held it in 30 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 45,826 shares of Arcus Biosciences worth $1.41M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 3,656 Arcus Biosciences shares in Q2 2026, an estimated $90.4K.
  • Arcus Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1781 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Arcus Biosciences in Q1 2019 and has held it in 30 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.